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Abstrak 
 
Penambahan nilai klinikal oleh I-131 SPECT/CT leher dalam rawatan pesakit 
“differentiated thyroid carcinoma” 
 
Tujuan: Untuk mengkaji penambahan nilai klinikal oleh SPECT/CT leher dan 
pengaruh ke atas rawatan pesakit “differentiated thyroid carcinoma”. 
 
Metodologi: Skan radioiodin I-131 seluruh badan secara planar dan SPECT/CT leher 
dijalankan ke atas 78 pesakit yang telah disahkan secara histopatologi mengidap 
“differentiated thyroid carcinoma”. Hasil skan seluruh badan secara planar dan 
SPECT/CT leher telah dianalisis. Analisa klinikal berdasarkan klasifikasi TNM untuk 
tahap kanser, status kumpulan stratifikasi risiko terjadinya kanser berulang dan 
rancangan rawatan dibuat berdasarkan hasil skan seluruh badan secara planar dan 
SPECT/CT leher dan dibuat perbandingan. Seterusnya, analisa ini digunakan untuk 
menilai kesan atau impak terhadap perancangan rawatan pesakit secara keseluruhan. 
 
Keputusan: Data daripada 78 pesakit dengan sejumlah 91 fokus radioiodin di bahagian 
leher diperiksa dan dianalisis oleh kedua-dua skan seluruh badan secara planar dan 
SPECT/CT leher. Pada analisis per fokus radioiodin, skan seluruh badan secara planar 
menghasilkan maklumat diagnostik pada 76 fokus (83.5%) di mana 49 fokus 
diklasifikasikan sebagai sisa kelenjar tiroid manakala baki 27 fokus diklasifikasikan 
sebagai nodus limfa. SPECT/CT leher menghasilkan maklumat diagnostik yang lebih 
besar iaitu pada 88 fokus radioiodin (96.7%). SPECT/CT leher telah mengubah 
diagnosis yang dibuat oleh skan radioiodin I-131 seluruh badan secara planar pada 30 
	 xiii	
fokus (33%, p <0.001). Pada analisis per pesakit, hasil skan radioiodin I-131 seluruh 
badan secara planar telah diubah pada 29 pesakit (37.2%, p <0.001) dari 78 pesakit 
selepas menilai maklumat yang dihasilkan oleh SPECT/CT leher. Klasifikasi tahap 
penyakit kanser tiroid menurut klasifikasi TNM telah disemak semula setelah mendapat 
maklumat yang diperolehi dari hasil SPECT/CT leher pada 8 (10.2%) dari 78 pesakit 
manakala kumpulan stratifikasi risiko terjadinya kanser berulang juga telah disemak 
semula selepas menilai maklumat yang dihasilkan oleh SPECT/CT leher pada 15 
(19.2%) dari 78 pesakit. Secara keseluruhannya, hasil SPECT/CT leher telah 
memberikan perubahan yang ketara ke atas perancangan rawatan pesakit “differentiated 
thyroid carcinoma” (p <0.001). 
 
Kesimpulan: SPECT/CT leher telah menunjukkan kesan perbezaan diagnostik yang 
ketara berbanding dengan skan radioiodin I-131 seluruh badan secara planar. 
SPECT/CT leher juga memberikan kesan yang ketara ke atas perancangan rawatan 
pesakit “differentiated thyroid carcinoma”. 
 
Kata Kunci: Differentiated thyroid carcinoma, iodine-131, planar scintigraphy, 
SPECT/CT. 
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Abstract 
 
The incremental value of I-131 SPECT/CT of the neck in the management of 
differentiated thyroid carcinoma. 
 
Aim: To assess the clinical value of single-photon emission computed 
tomography/computed tomography (SPECT/CT) of the neck in the management of 
differentiated thyroid carcinoma (DTC). 
 
Material and methods: I-131 planar whole body scan and SPECT/CT of the neck were 
performed in 78 patients with histologically confirmed diagnosis of differentiated 
thyroid carcinoma. The scan findings made by each I-131 planar whole body scan and 
SPECT/CT of the neck were analysed. Clinical staging based on TNM staging 
classification and risk stratification group were assessed and compared based on 
information given by each I-131 planar whole body scan and SPECT/CT of the neck. 
Subsequently, clinical management plan made by each planar and SPECT/CT of the 
neck were assessed and compared for significant impact on overall patient management.   
 
Results: Data from 78 patients with total of 91 radioiodine foci in the neck region was 
observed and analysed by both I-131 planar whole body scan and SPECT/CT of the 
neck. On lesion based analysis, I-131 planar whole body scan yield diagnostic 
information in 76 foci (83.5%) in which 49 foci were classified as thyroid remnant 
while the remaining 27 foci were classified as lymph node. SPECT/CT of the neck yield 
a better diagnostic information in 88 foci (96.7%). SPECT/CT of the neck has changed 
diagnosis given by I-131 planar whole body scan in 30 foci (33%, p<0.001). On patient 
	 xv	
based analysis, the findings of I-131 planar whole body scan were altered in 29 (37.2%, 
p<0.001) out of 78 patients in based on SPECT/CT findings. Clinical staging according 
to TNM classification was revised with additional information obtained by using 
SPECT/CT in 8 (10.2%) of 78 patients. The risk stratification group was revised with 
additional information obtained from SPECT/CT in 15 (19.2%) of 78 patients. 
SPECT/CT of the neck may significantly alter the personalised treatment planning for 
each patient with differentiated thyroid carcinoma (p<0.001). 
 
Conclusion: SPECT/CT of the neck has shown a significant diagnostic impact as 
compared to I-131 planar whole body scan alone. SPECT/CT also had a significant 
impact on the management of patients with differentiated thyroid carcinoma.  
 
Keyword: Differentiated thyroid carcinoma, iodine-131, planar scintigraphy, 
SPECT/CT. 
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CHAPTER 1 
RESEARCH BACKGROUND 
 
1.1 Introduction  
  
 Differentiated thyroid carcinoma (DTC) arising from thyroid follicular epithelial 
cells is a slow-growing malignancy which accounts for the vast majority (90%) of all 
thyroid cancers. Histologically, DTC consists of two subtypes, namely papillary 
carcinoma which comprises the large group (85%) of DTC and follicular carcinoma 
(10%) while the remaining (5%) of the DTC cases are from these two cells variant 
(Omar et al., 2006). 
 According to Malaysian National Cancer Registry Report for the period of 
2007-2011 (2012), thyroid cancer was ranked seventeenth among males and ninth 
among females.  Based on gender, there is female preponderance for DTC with female 
to male ratio is approximately 3:1 and the lifetime risk for thyroid cancer was 1 in 336 
for females and 1 in 884 for males. Staging was reported for 671 cases in females and 
213 cases in males, 60% were diagnosed at stage I and II in females and 48% in males. 
The incidence rate based on ethnicity was the highest among Malays (72.5%), followed 
by Chinese (22.6%), Indian (6.6%) and others (12.1%). 
 The prognosis of DTC is highly favourable. The United State National Cancer 
Database for Thyroid Carcinoma has reported that patient with papillary and follicular 
thyroid carcinoma has a high 10-year overall survival rate of 93% and 85%, 
respectively (Enewold et al., 2009). Another study has reported that the 10-year overall 
survival rate was 76.8% while cause-specific survival rates was 84.9% (Eustatia et al., 
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2006). As in the case of other malignant tumours, the mortality of this disease depends 
on several factors. Disease prognosis is critically determined by the presence of regional 
or distant metastases. A study has concluded that in thyroid carcinoma the overall 
survival and diseases recurrence are significantly influenced by involvement of regional 
lymph node metastases (Scheumann et al., 1994). Moreover, lymph node metastases 
remained as an independent highly significant prognostic marker for more aggressive 
DTC regardless of the other risk factors such as older age, tumour invasion and distant 
metastases (Podnos et al., 2005; Durante et al., 2006). This evidence was also supported 
in a study which reported that in patients with metastasis, the 10-year overall survival 
rates has significantly decreased to 24% and cause-specific survival rate has also 
decreased to 27%, significantly (Dinneen et al., 1995). 
 Despite the favourable prognosis, optimal outcomes are achieved only via 
coordinated multiple treatment modality. The goal of initial therapy of DTC are to 
remove the primary malignant tumour and locoregional involvement therefore to 
minimize risk of disease recurrence and also regional and distant metastatic disease. 
These can be achieved with the worldwide accepted initial treatment which consist of 
surgical removal of thyroid glands (total thyroidectomy) followed by radioiodine 
ablation therapy (RAI) with Iodine-131 (Luster et al., 2008; ATA Guidelines, 2009;).  
 
1.2 Literature Review  
 Radioiodine ablation therapy has been established as an effective adjuvant 
therapy for patients with DTC. It utilizes Iodine-131 as theranostic radioisotope which 
emits gamma rays for scintigraphic imaging for diagnostic purpose and beta particles 
for therapeutic effect (DeGroot et al., 1990; Samaan et al., 1992; Mazzaferri et al., 
1994). 
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 Iodine-131 is concentrated within tissues expressing sodium iodide symporters 
(NIS) including thyroid cells and metastatic DTC. NIS expression is the determinant 
factor for selective Iodine-131 uptake in both normal thyroid tissues and in up to 80% 
of thyroid carcinoma cells. This uptake occurs through an electrochemical sodium 
gradient generated by sodium-potassium adenosine triphosphates. Therefore, this 
important tumour cell characteristic makes Iodine-131 a useful therapeutic as well as 
diagnostic (theranostic) tool for the management of DTC (Oh et al., 2012).  
 NIS is physiologically expressed in various glandular cells: thyroid cells, ductal 
cells of salivary glands, parietal and mucous-secreting cells lining of the gastric mucosa, 
lacrimal glands, choroid plexus, ciliary bodies of the eye, thymus, placenta, and 
lactating mammary glands. NIS expression is also detected in most neoplastic cells of 
locoregional and distant metastases of DTC. As a consequence, Iodine-131 whole body 
scan (WBS) may show radioiodine uptake not only in thyroid remnants or metastases 
from DTC, but also in physiological non-thyroidal NIS expression tissue (Oh et al., 
2012). 
 Previous studies have found that radioiodine therapy improves the clinical 
prognosis of patients provided there is accumulation of Iodine-131 in the metastatic 
foci, despite having distant metastases. These iodine-131 avid metastatic foci have 
shown histological characteristic of DTC (Schlumberger et al., 1996; Bernier et al., 
2001). Therefore, an accurate and precise localization and structural characteristic of 
iodine-131 avid metastatic foci are essential in the diagnosis of local recurrence, lymph 
nodes metastases and distant metastatic sites. Hence, the reliable and accurate 
determination of cancer staging based on TNM classification and risk stratification 
group for cancer recurrence and eventually, the adequate clinical follow-up and 
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management of patients with differentiated thyroid carcinoma. Correctly interpreted 
findings of Iodine-131 scintigraphy can be of great benefit for patients with DTC.  
 Conventionally, the Iodine-131 scintigraphy has been performed as a whole-
body planar scan (WBS). This planar scintigraphy in association with routine 
biochemical marker measurements (serum thyroglobulin, serum anti-thyroglobulin-
antibody and serum TSH) are still considered as part of the routine diagnostic procedure 
for DTC patients in Malaysia. This modality is used in the detection of remnant thyroid 
tissue and locoregional or distant metastases after total thyroidectomy for initial staging 
and after radioiodine ablation therapy for restaging and long-term follow-up. However, 
the image may be noisy and have low resolution because it is a projection image from a 
higher-energy radioisotope, Iodine-131. Furthermore, the lack of anatomical landmarks 
as well as the possibility of various other benign or physiological Iodine-131 uptake, 
may complicate the image interpretations (Xue YL et al., 2013). In the era of emerging 
advanced medical imaging system, single photon emission computed 
tomography/computed tomography (SPECT/CT) has been increasingly used. Diagnostic 
accuracy of SPECT has been reported to be improved by new SPECT/CT fusion images 
in various clinical situations (Kohlfuerst et al., 2009). Therefore, their timely 
recognition may lead to accurate detection of an otherwise clinically occult tumour at an 
early and highly treatable stage. 
 Iodine-131 SPECT/CT has been demonstrated to overcome the limitation or 
pitfall of planar imaging by accurate and precise localisation and characteristic of 
pathological and physiological sites of radioiodine uptake. A study done among 123 
patients with DTC in 2010 have shown that the sensitivities of SPECT/CT and planar 
imaging were comparable and did not show superiority in one to another (both 62%) 
(Menges et al., 2012). However, specificity of planar imaging has significantly 
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improved by SPECT/CT with specificity of 78% and 98%, respectively (Thust et al., 
2009). Another study to assess the diagnostic performance of co-registered SPECT/CT 
compared to Iodine-123 planar WBS imaging and to SPECT alone in patients with DTC 
has showed that there is no significant difference in sensitivity of planar WBS (41%) as 
compared to SPECT (45%) and SPECT/CT (50%) imaging. However, the specificity of 
planar WBS (68%) has significantly improved by the addition of SPECT (89%) and 
SPECT/CT (100%) imaging. Moreover, SPECT/CT was also showed a significantly 
higher positive predictive value (PPV 100%) as compared to planar WBS (31%) and 
SPECT alone (59%) (Barwick et al., 2009). This data has proven that the diagnostic 
information has significantly improved by addition of SPECT/CT as compared to planar 
WBS or SPECT imaging alone (Tharp et al., 2004). The clinical value of SPECT/CT in 
the management of DTC patients is still being investigated by many authors. Previous 
studies so far had shown diverse results because of various target populations, different 
clinical settings and different analysis protocols (Tharp et al., 2004; Ruf J. et al., 2004; 
Chen et al., 2008; Wong et al., 2008; Schmidt et al., 2009; Kohlfuerst et al., 2009; 
Grewal et al., 2010; Wong et al., 2010; Yasuhiro M et al., 2012; Menges et al.,2012; 
Valentina et al., 2016). 
 
1.3 Research Problem  
  
 In the era of emerging advanced imaging modality, without any doubt studies 
has proven that SPECT/CT has superior diagnostic accuracy as compared to 
conventional planar scintigraphy in various clinical situations. In the case of DTC, 
SPECT/CT have been reported to improve the diagnostic accuracy in detecting nodal 
and distant metastases as compared to planar scintigraphy alone. Iodine-131 SPECT/CT 
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has also been demonstrated to overcome the limitation or pitfall of planar scintigraphy 
in characterizing and localizing pathological and physiological sites of radioiodine 
uptake.  
 SPECT/CT has been introduced to our institution since early 2014. Ever since, 
SPECT/CT in addition to planar scintigraphy has shown a significant impact to our 
service of care in various aspect. SPECT/CT has increased the level of confidence 
among nuclear medicine doctors in interpreting various type of nuclear medicine 
scintigraphy including the radioiodine scintigraphy performed for all patients treated 
with radioiodine ablation therapy. Nevertheless, the clinical value of SPECT/CT in the 
management of differentiated thyroid carcinoma patients in Malaysian populations is 
yet to be investigated.  
 Despite the facts, SPECT/CT hybrid imaging is quite a new modality with 
limited availability in the government hospitals in Malaysia. As a consequence, Iodine-
131 planar scintigraphy has remained the standard procedure for patient with DTC who 
undergoes radioiodine ablation therapy in Malaysia. 
 The question arises whether the additional value of SPECT/CT hybrid imaging 
may provide a clinical relevance to the management of patient with DTC and eventually 
give a significant impact to the standard quality of care in Malaysia? 
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1.4 Justification of Study        
 
 We conduct a study which aim to provide evidence of the incremental value and 
clinical relevance of SPECT/CT of the neck in the management of patient with DTC 
who had radioiodine ablation therapy and therefore improving the standard quality of 
care in Malaysia.  
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1.5 Objectives 
  
1.5.1 General Objective 
§ To assess the clinical value of SPECT/CT of the neck in the management of DTC. 
1.5.2 Specific Objectives 
§ To determine the correlation of image interpretation between planar WBS and 
SPECT/CT of the neck. 
§ To determine the significance of SPECT/CT diagnostic value on staging and risk 
stratification of DTC. 
§ To determine the impact of SPECT/CT diagnostic value on therapeutic planning for 
DTC. 
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1.6 Research Hypothesis  
Null Hypothesis 
• SPECT/CT of the neck has no significant incremental clinical value in the 
management of patient with DTC. 
 
Alternate Hypothesis 
• SPECT/CT of the neck has significant incremental clinical value in the 
management of patient with DTC. 
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CHAPTER 2 
MATERIALS AND METHODS 
 
2.1 Study Design and Location  
 
This prospective cohort study was conducted in Nuclear Medicine Department, Kuala 
Lumpur General Hospital. 
 
2.2 Study Population and Recruitment Time Frame  
 
 The study population was derived from patients with histopathologically 
confirmed diagnosis of DTC and had undergone total thyroidectomy. They were 
referred to Nuclear Medicine Department, Hospital Kuala Lumpur for radioiodine 
ablation therapy. The post therapy scintigraphy (RxWBS) showed radioiodine sensitive 
foci in the neck with no other abnormal distant foci elsewhere. They are recruited into 
this study when the subsequent scheduled diagnostic scintigraphy (DxWBS) showed 
persistent positive foci in the neck.  
The data collection duration was between 1st April 2016 till 30th April 2017.  
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2.3 Inclusion and Exclusion Criteria    
 
2.3.1 Inclusion criteria 
1. Male/female aged ≥ 18 years’ old 
2. Histopathologically confirmed diagnosis of DTC 
3. Had total thyroidectomy 
4. Undergo radioiodine ablation therapy 
5. Had persistent radioiodine sensitive foci in the neck with no other abnormal 
distant foci elsewhere in both post therapy scintigraphy (RxWBS) and 
subsequent diagnostic scintigraphy (DxWBS). 
 
2.3.2 Exclusion criteria 
 
Patient who does not give consent to this study.  
 
2.4 Ethical board  
 
 The study was approved by the Universiti Sains Malaysia Human Research 
Ethics Committee and Medical Research and Ethics Committee, Kementerian Kesihatan 
Malaysia (refer appendix 4 (a) and (b)). Written informed consent was obtained from all 
the patients who were included in the study. 
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2.5 Sample Size Calculation  
 
 The sampling population was derived from DTC patients who were referred to 
Nuclear Medicine Department, Hospital Kuala Lumpur for radioiodine ablation therapy. 
Total new DTC patient per annum was 97 patients in 2015 (based on source from 
Nuclear Medicine Department, Hospital Kuala Lumpur patient data registry). The 
prevalence of regional lymph node metastasis (neck region) in DTC patient is 20-50% 
(ATA Guidelines, 2009). 
 The sample size calculation was done using Epi Info 3.1.5 based on sample size 
formula for population survey. The required sample size to achieve a power of 80% and 
confidence interval of 95% is 70 patients.   
 
2.6 Research Tool  
 
a. Data sheet to compile patient’s information (refer appendix 1). 
b. Data sheet for data collection for each patient (refer appendix 2a).  
c. Data sheet for follow-up data (refer appendix 2b) 
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2.7 Sampling Method and Procedures 
 
The following procedures had been carried out during the patient recruitment: 
 
1. All DTC cases referred to Nuclear Medicine Department, HKL for 
radioiodine ablation therapy had been discussed during clinical meeting with 
Nuclear Medicine Specialist and then scheduled for radioiodine ablation 
therapy.   
2. Following the radioiodine ablation therapy, patient was routinely undergone 
post therapy scintigraphy (RxWBS).  
3. All patients with RxWBS result of radioiodine sensitive foci in the neck 
(with no other abnormal distant foci elsewhere) were identified. The doctor 
in-charge scheduled them for next diagnostic iodine-131 scintigraphy 
(DxWBS) in 4-6 months’ time.  
4. On the appointment day for DxWBS, the doctor in-charge clerked and 
performed physical examination to the patient. After taking low dose 
radioiodine, patient was discharged and came back in 2-3 days time for 
DxWBS.  
5. On the DxWBS scan day, all patients with resolved radioiodine sensitive 
foci in the neck were excluded from this study.  
6. The patients with persistent radioiodine sensitive foci in the neck were 
included into this study. The patients then proceeded with SPECT/CT of the 
neck on the same day.  
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7. Both planar and SPECT/CT findings were interpreted by the Nuclear 
Medicine Specialist in-charge and further management plan decided was 
documented in the patient’s folder. 
8. The patient was given an appointment date for clinic follow-up in at least 
two to three months’ time by the doctor in-charge to review any 
investigation results to support the diagnosis including the histopathological 
report or other imaging modalities (US, diagnostic CT or MR) report and the 
results of relevant biochemical markers.  
9. The patient had been explained about the study details beforehand. Informed 
consent had been signed for their participation in this study. 
10. Data collection was recorded in data collection forms (refer appendix 1 and 
2) for further data analysis.  
 
 The procedures mentioned above was a standard procedure for the management 
of DTC patient referred to Nuclear Medicine Department, HKL for radioiodine therapy. 
A written informed consent was obtained for the participation of the patient in this study 
and data collection. 
 Patient’s management plan was made by the Nuclear Medicine Specialist in-
charge regardless their participation in the study. Data collection for the study purpose 
were the secondary data obtained from the patient’s file and scan reports including 
whichever result available during the follow-up as reference standard.  
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2.8 Conceptional Framework (Flow Chart)  
 
  
 
DTC patient who was referred for radioiodine ablation therapy 
Diagnostic radioiodine planar scintigraphy (DxWBS) 
(scheduled by the doctor in-charge in 4-6 months time)  
 
 (at least after 2-3 months) 
Follow-up: Completion of data collection 
 
Determination of study eligibility: 
 
1.Male/female aged ≥ 18 years’ old 
2.Histopathologically confirmed diagnosis of DTC 
3.Had total thyroidectomy 
4.Undergo radioablation therapy and post therapy scintigraphy shows 
radioiodine sensitive foci in the neck with no other abnormal distant 
foci elsewhere.  
Data collection  
for each planar sintigraphy and SPECT/CT of the neck 
• Classification of foci* 
• Determination of staging and risk of disease recurrence category 
(risk stratification) 
• Management plan  
 
 
Data analysis and statistical analysis : 
 
• Per lesion analysis 
• Per patient analysis 
Within the same day, proceed with SPECT/CT of the neck 
(decision made by the doctor in-charge)  
 
DxWBS with RESOLVED neck focus 
à EXCLUDED from study  
 
DxWBS with persistent radioiodine sensitive foci in the neck  
à INCLUDED in study 
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*Classification of radioiodine sensitive foci (Schmidt et al., 2009): 
1. Thyroid remnant [focus +] 
2. Radioiodine sensitive lymph node [focus +] 
3. Indeterminate focus (Equivocal) 
4. Benign/physiological focus [focus -] 
 
**Reference Standard (Chen et al., 2008; Yasuhiro M et al., 2012). 
The reference standard is to confirm the diagnosis of the radiosensitive foci from the 
interpretation of the iodine-131 scintigraphy alone or with SPECT/CT images. The 
reference standard is at least one of the following methods: 
a. Histopathological diagnosis of tissue sample taken from surgical resection or 
tissue biopsy.   
b. Diagnostic imaging of the neck by using other diagnostic imaging modalities i.e. 
US, diagnostic CT or MR imaging. 
c. Clinical follow-up with biochemical data (serum thyroglobulin, serum anti-
thyroglobulin-antibody, serum TSH) at least after two to three months.  
 
2.9 Variable Definitions  
 
a. Planar whole body scan (Schmidt et al., 2009). 
 
Radioiodine sensitive focus is defined as any focus with uptake greater than the 
background level; is localised according to reader observation:  
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• Benign/Physiological focus: uptake in the nose and symmetrical uptake in the 
salivary glands 
• Thyroid remnant:  
-  Focus of uptake localized in the thyroid bed or     
-  Midline focus superior to the thyroid bed (pyramidal lobe) 
• Radioiodine sensitive lymph node: Focus at a greater distance lateral to the 
thyroid bed 
• Indeterminate focus (Equivocal):  
- Focus adjacent to the thyroid bed or medial portion of the neck 
- Asymmetrical focus within the level of the neck 
 
b. SPECT/CT of the neck (Schmidt et al., 2009). 
 
SPECT/CT of the neck: The field of view covers from basal of skull to the level of mid 
sternum. 
Radioiodine sensitive focus is defined as all foci with uptake greater than the 
background level with CT correlation of specific anatomical structure: 
• Benign/Physiological:  Physiologic anatomical structure. 
• Thyroid remnant: Focus of uptake localized in the thyroid bed/pyramidal lobe.  
• Radioiodine sensitive lymph node: Focus in levels I–VI and VII collocated with 
lymph node visible on CT (The localisation of the node is according to the 
cervical lymph node classification levels published by the 7th AJCC in 2009)  
• Indeterminate focus (Equivocal): Focus in levels I–VI and VII without lymph 
node visible on CT. 
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2.10 Data and Statistical Analysis  
 
2.10.1 Data Collection tool and data management. 
 
 A data collection forms (appendix 1 and 2) were designed for the purpose of 
data collection. Appendix 1 is the form consist of patients’ demographic information, 
clinical features and the other relevant investigation results and treatment history. 
Appendix 2 is divided into section A and B. Section A covers the result of I-131 planar 
scintigraphy and SPECT-CT image interpretations and analysis.  Section B covers the 
supportive data from any of the reference standards. The source of data are from the 
patients’ medical record and the scintigraphic images.  
 Data has been keyed-in into spreadsheet MS excel which was then exported to 
STATA version 11 (1) to proceed with data cleaning and data analysis. 
 
2.10.2 Statistical analysis 
 
 A generalized McNemar or Stuart–Maxwell test was used to determine whether 
the assignment of scan findings, TNM staging, risk stratification and management plan 
by planar WBS and SPECT/CT of the neck had the same distribution. In addition, a 
weighted kappa statistic was computed to estimate the level of concordance/agreement 
between the two methods, with regard to TNM staging and risk stratification. Table 1 
shows the guidelines for interpreting kappa statistics as suggested by Landis and Koch  
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Table 1: Interpretation of kappa statistic 
Kappa Agreement 
<0  poor agreement 
0.01–0.20 slight agreement 
0.21–0.40 fair agreement 
0.41–0.60 moderate agreement 
0.61–0.80 substantial agreement 
0.81–1.00 almost perfect agreement 
  
 The findings of planar WBS and SPECT/CT of the neck were compared with 
the reference standard of either a histopathologic diagnosis, diagnostic imaging by using 
other modalities of US, diagnostic CT or MR imaging or clinical follow-up with 
biochemical data (serum thyroglobulin, serum anti-thyroglobulin-antibody and serum 
TSH). For the purpose of these calculations, equivocal findings were excluded by each 
method. Comparison of the diagnosis of DTC by each method was performed using an 
exact McNemar’s test.  
 All p-values reported were two sided, and a p-value of less than 0.05 was taken 
as the critical limit to determine the significance difference. Data were analysed using 
Stata software (Stata/SE 14, College Station, TX, USA). 
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2.11 Privacy and Confidentiality  
 
 In order to protect the patients’ privacy and confidentiality, management of 
confidential information of the research subject is crucial. To meet the purpose, each of 
the participants subjected into the study has been given specific code number to create a 
‘clean’ data set. This clean data set did not contain information the subject’s 
identification. The identifying information including the master reference list of patients 
with the code number and other document containing subject information has been kept 
safely according to the following data protection plan: 
1. All files containing data in the computer has been kept with password 
protection. 
2. All removable storage media holding the data (e.g., CDs, hard disk, 
removable drive, etc.) are kept in a locked compartment when not in use 
3. Printouts derived from data analysis stored in a locked compartment when 
not in use. 
All these documents will be kept in storage for 5 years and then will be destroyed in a 
secure manner.  
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CHAPTER 3 
RESULTS AND DISCUSSION 
 
3.1 Results 
3.1.1 Patient Demographics 
 
 A total number of 78 patients with histologically confirmed differentiated 
thyroid carcinoma were identified and included in the study. The demographic details of 
the patients are shown in table 2. I-131 planar WBS and immediately followed by 
SPECT/CT of the neck were done for all the patients. From the total number of patients, 
58 (74.4%) were females and 20 (25.6%) patients were males.  
 The patients were predominantly Malays which comprised of slightly more than 
half of the total cases at 64.1%, followed by Chinese 19.2%, Indian 11.5% and others 
5.1%.  
  The mean age at diagnosis is 42 years old. For the purpose of TNM staging for 
thyroid carcinoma, the patients were divided into two age groups; age group of less than 
45 years old which comprised of 40 patients (51.3%) and age group of equal or more 
than 45 years old which comprised of 38 patients (48.7%) from the total number of 
patients included in the study.  
 Majority of the patients were diagnosed with papillary thyroid carcinoma which 
comprised of 85.9%, followed by follicular thyroid carcinoma which comprised of 
11.5%. Other type of thyroid carcinoma (ie. Hurtle Cell Carcinoma) was identified in 
two patients which comprised of 2.6%. 
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Table 2: The demographic profiles of the study population (N=78) 
 n (%) 
Age at diagnosis, years*:   
Mean (SD) 42.73 (16.46) 
Range 18, 74 
Gender:   
Male 20 (25.6) 
Female 58 (74.4) 
Race:   
Malay 50 (64.1) 
Chinese 15 (19.2) 
Indian   9 (11.5) 
Others   4 (  5.1) 
*Numerical values. 
SD = Standard deviation; Range = minimum, maximum. 
 
Figure 1: Bar chart shows the distribution of study population by age group (N=78) 
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Figure 2: Pie chart shows the distribution of study population by ethnicity/race (N=78) 
 
 
 
 
Table 3: The histopathological type of the study population (N=78) 
 n (%) 
 
Histopathological type: 
  
Papillary thyroid cancer 67 (85.9) 
Follicular thyroid cancer   9 (11.5) 
Others   2 (  2.6) 
*Numerical values. 
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Figure 3: Pie chart shows the histopathological type of the study population (N=78) 
 
 
 
3.1.2 Lesion Based Analysis 
 
 In 78 patients, there were 91 foci observed on both I-131 planar WBS and 
SPECT/CT of the neck. The SPECT/CT of the neck were done on all the 78 patients 
which I-131 planar WBS showed uptake greater than the background level. I-131 planar 
WBS yield diagnostic information in 76 foci (83.5%) in which 49 foci were classified 
as thyroid remnant while the remaining 27 foci were classified as lymph node. 
SPECT/CT of the neck yield a better diagnostic information in 88 foci (96.7%). 38 foci 
were classified as thyroid remnant, 33 foci as lymph node and the remaining 17 foci 
were classified as benign or physiological foci.  
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